Steroid Phobia
Steroid phobia (topical corticophobia) means fear, worry or negative beliefs about using Topical Corticosteroids (TCS). Patients and parents of children with Atopic Dermatitis report it often. It is a spectrum, not a yes/no state: some parents say they are not worried but still show it in what they do, by asking again and again for reassurance or quietly using less cream than prescribed (Moret et al., PLoS One 2013). To capture this, French researchers built the TOPICOP Scale, a 12-item questionnaire covering “worries” (6 items) and “beliefs” (6 items), scored 0–100%. It was validated in 208 respondents, 144 of them parents, with Cronbach’s α of 0.79 and 0.78. It is now the standard research tool, and the parent surveys below use it.
TOPICOP Scale [defines] Steroid Phobia Steroid Phobia [opposes] Topical Corticosteroids Steroid Phobia [relates] Atopic Dermatitis
How common is it among parents? It is very common, but the figure depends on how it is measured. A 2017 systematic review of 16 cross-sectional studies found prevalence of 21.0% to 83.7% (Li et al., JAMA Dermatology 2017). The TOPICOP authors cite 40–73% from earlier work, and in their own sample 80.7% admitted to having fears about TCS. In TOPICOP surveys of parents, the median score was 66.6% among 301 parents in Taif, Saudi Arabia (2023), with nearly two-thirds classed as phobic. The mean was 39.1% among 100 Italian parents, but 49% of those scored above 50%, the “severe” range (Herzum et al., J Clin Med 2023). In the Italian study, the strongest predictors of severe parental phobia were a high parental quality-of-life burden (DLQI; OR 38.5), a child older than 4 (OR 14.5), eczema that started before age 1, and higher parental education (OR 4.1). Parents of children aged 4 or under scored lower on average. The authors suggest that parents pick up contradictory advice the longer the disease lasts. So for toddler families, the window when fear is still forming is also the best time to give clear information.
Steroid Phobia [worsens] Atopic Dermatitis
Conflict: [Li et al., JAMA Dermatology 2017] reports TCS phobia prevalence of 21.0–83.7% across 16 studies. [Moret et al., PLoS One 2013] cites 40–73% and found 80.7% admitting fear on a single yes/no item. [Herzum et al., J Clin Med 2023] found 49% “severe” (TOPICOP >50%) in Italian parents. Prevalence depends on the instrument and cut-off, so “40–80% of parents” is a range of definitions, not one estimate. Unresolved — add to open_questions.
Effect on adherence and outcomes, and the push toward “natural” care. Phobia goes with much worse adherence. In the 2017 review, non-adherence was 49.4% vs 14.1% (and 29.3% vs 9.8%) in phobic vs non-phobic groups. In the Taif study, 44.5% of parents had stopped TCS because of side-effects they believed they saw, and 21.6% did not follow the doctor’s instructions. Under-treatment then becomes a vicious cycle. Too little cream, used too briefly, leads to poor results. Poor results “confirm” the parents’ doubts, and the cycle continues, which Herzum et al. call “TCS demonization”. Families who give up on conventional care become “particularly susceptible” to misinformation about alternative causes and cures, and turn to non-conventional options. In a Leicester clinic, 17% of families using complementary medicine gave fear of steroid side-effects as their reason (Johnston 2003; see Herbal and Home Remedies for Eczema). That route can end in a cream that is itself a hidden steroid. In Birmingham, 20 of 24 “herbal” creams used by children contained steroids, some of them clobetasol (Ramsay 2003; see Adulterated Herbal Creams). Fear of the black-box warning on Topical Calcineurin Inhibitors works the same way for the main steroid-free prescription option.
Steroid Phobia [causes] Herbal and Home Remedies for Eczema Steroid Phobia [causes] Adulterated Herbal Creams Steroid Phobia [precedes] Chinese Herbal Medicine Steroid Phobia [opposes] Weekend Therapy
"Steroid-free" natural creams can contain undeclared steroids
Parents who avoid prescribed steroids out of fear may end up applying a potent or very potent steroid with no label, no potency and no time limit. Lab tests of UK “herbal” eczema creams have repeatedly found Clobetasol Propionate. The MHRA says this is contraindicated under age 1 and should never be sold directly to the public. Only use creams with a UK licence/THR number or a pharmacist-labelled potency.
Social-media drivers. Much of today’s fear comes from online accounts of Topical Steroid Withdrawal (TSW). Mentions of topicalsteroidwithdrawal across platforms rose 274% between 2016 (n = 2,138) and 2020 (n = 7,992) (Bowe et al., Clin Exp Dermatol 2022). The 2024 UK joint statement notes that TSW has more than 1.1 billion TikTok views. In a 2025 content analysis, 82–84% of top TSW posts on Instagram and TikTok were personal stories. Non-physician “educational” posts scored below 3/5 for accuracy and safety, while physician posts scored 4.25/5. These posts promoted cold-plasma therapy, No Moisture Therapy, red-light therapy and avoiding all steroids (Zhu et al., Cureus 2025). UK dermatologists report that patients who self-diagnose TSW mostly cite social media (82.5%) and internet searches (68.9%). Only 6.8% cite their GP (Skin Health and Disease 2025 survey).
Topical Steroid Withdrawal [causes] Steroid Phobia Steroid Phobia [relates] Topical Steroid Withdrawal
How clinicians address it. Professional guidance takes a consistent line: validate the worry, then give concrete instructions. The MHRA (2021, 2024) tells prescribers to choose the lowest effective potency, say exactly how much to apply (see Fingertip Unit), where, how often and when to stop, and to warn that too little cream can prolong treatment. From 2024, UK packs carry “mild / moderate / strong / very strong steroid” labels so parents can see the potency. The joint statement from the National Eczema Society, British Dermatological Nursing Group and British Association of Dermatologists (2024) says concerns about TSW “should not put people off using topical steroids when they can help”. It asks clinicians to “find common ground” and to offer alternatives to people who would otherwise stop. NICE tells clinicians to explain that benefits outweigh harms when TCS are used correctly. Study authors recommend screening with TOPICOP, structured parent education programmes, and doctors acting as the main trusted source of information (Taif 2023; Herzum 2023). The evidence has a weak spot of its own. In a UK survey, dermatologists rated a patient who self-diagnosed TSW as “more likely to pose difficult management problems” (3.83 vs 2.81/5), a bias that may push families further toward online communities.
MHRA [opposes] Steroid Phobia National Eczema Society [opposes] Steroid Phobia British Association of Dermatologists [opposes] Steroid Phobia Fingertip Unit [prevents] Steroid Phobia
Conflict: Parent-community posts (Reddit r/beyondthebump, c. 2025; anecdotal) tell parents “Please stop using steroids; they are very harmful to the skin”. [NES/BDNG/BAD joint statement, Feb 2024] says topical steroids “can be used safely and effectively” for eczema and that TSW “affects only a small proportion of patients seen by dermatologists”. [MHRA DSU, May 2024] calls TSW rare against more than 11 million UK prescriptions a year, but says its frequency “cannot be confirmed”. Unresolved — add to open_questions.
What parents report
evidence: anecdotal. These are Brave Search snippets of Reddit threads, not full threads. The Reddit tool failed, and the sample is unsystematic.
- A parent on r/ScienceBasedParenting says the steroid is “the only thing so far (we have LOTS of non steroid remedies)” that relieved their baby’s itch, “but now i’m terrified that he’s going to develop TSW”. Another says they “had to actively avoid any Facebook groups about eczema or steroids because it was ALL about TSW”.
evidence: anecdotal - Several parents of babies aged 3–5 months say they are “too scared” of steroid side-effects to start a prescribed cream. A parent of a 1-year-old reads the overnight flare after a 2-week desonide course as possible TSW.
evidence: anecdotal - In an r/eczema thread titled “I’m scared of using steroids on my baby”, one reply offers “a Chinese cream that was recommended by a friend … I’m not Chinese and can’t read the label/brand”, and several parents ask for details. Others suggest diluting the steroid with moisturiser, or shea butter.
evidence: anecdotal - Counter-reports also appear. In the 412-vote r/eczema post “TSW is rare. Please use steroids.”, users write that they had been “so scared to use my steroids” because of posts in the sub. A parent of a 16-month-old says that baths, moisturiser and spot steroid treatment left the eczema “basically gone”.
evidence: anecdotal
Connections
- Topical Corticosteroids — parental fear reducing TCS adherence, source: Li JAMA Derm 2017; Taif 2023
- Herbal and Home Remedies for Eczema — fear of side-effects drives 17% of CAM use in Leicester sample, source: Johnston 2003
- Adulterated Herbal Creams — fear of prescribed steroids drives purchase of steroid-spiked ‘herbal’ creams, source: Ramsay ADC 2003
- TOPICOP Scale — validated 12-item measure of corticophobia, source: Moret PLoS One 2013
- Topical Steroid Withdrawal — online TSW content is main modern driver of fear, source: Bowe CED 2022; Zhu Cureus 2025
- MHRA — counselling advice and 2024 potency labelling, source: MHRA DSU 2021, 2024
- National Eczema Society — joint statement: TSW concerns should not stop helpful TCS, source: NES/BDNG/BAD 2024
- British Association of Dermatologists — co-author of 2024 TSW statement, source: NES/BDNG/BAD 2024
- No Moisture Therapy — promoted online as steroid-free alternative, source: Zhu Cureus 2025
- Weekend Therapy — fear is a barrier to proactive TCS on clear skin, source: Weekend Therapy note
- Topical Calcineurin Inhibitors — boxed-warning fear parallels TCS fear, source: TCI note
- Fingertip Unit — concrete dosing reduces under-use, source: MHRA DSU 2021
- Eczema Prognosis — no evidence TCS ‘drive eczema inward’ or cause asthma, source: Moret 2013; Illi 2004
- Eczema Education Programmes — education targets TCS under-use, source: Kannenberg 2020
- Treatment Outcomes Comparison — non-adherence is Track B’s main weakness, source: 2017 review
- AAD Pediatric Guideline 2026 — caregiver TCS distress averaged 6.5/10; under-treatment flagged, source: JAAD 2026